Drug Interaction Report

Colchicine and Dronedarone: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Dronedarone

Multaq
+

Colchicine

Colcrys Colcrys® Gloperba Gloperba® Lodoco Mitigare
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Contraindicated
These should generally not be used together.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 223 documented Colchicine interactions, 103 are rated contraindicated — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger Theoretical
The Bottom Line
Dronedarone raises colchicine levels and this pairing is contraindicated, especially with kidney or liver impairment; do not combine without your care team specifically adjusting the colchicine dose and monitoring you closely.

Taking these two together needs a close look from your care team. Colchicine (for gout or familial Mediterranean fever) is broken down and pushed out of your body by two systems in your gut and liver. Dronedarone (Multaq, for heart rhythm) slows both of those systems down. That means colchicine can build up to higher levels than intended.

Too much colchicine can cause serious problems like severe diarrhea, muscle weakness, and effects on your blood cells, and in rare cases it can be life-threatening. Please do not stop or change either medicine on your own. Talk with your pharmacist or doctor, because this combination often needs to be avoided or the colchicine dose carefully lowered and watched.

Interaction: Dronedarone is a dual CYP3A4 and P-gp inhibitor. Colchicine is a substrate of both. Inhibition reduces colchicine metabolism and efflux, increasing colchicine exposure and risk of toxicity (myelosuppression, neuromyopathy, GI toxicity, multi-organ failure). Neither is a prodrug; the effect is a straightforward increase in colchicine levels.

  • Direction: increased colchicine exposure
  • Evidence: theoretical, but analogous to fatal cases with clarithromycin
  • Severity: contraindicated, especially with renal or hepatic impairment

Management: Avoid combination. If required with normal renal/hepatic function, reduce colchicine dose or frequency per labeling (e.g., gout flare 0.6 mg x1, repeat no sooner than 3 days) and monitor closely; discontinue colchicine if toxicity suspected.

Onset
unspecified
Evidence
theoretical
Severity
Contraindicated

What happens

Increased colchicine exposure and an increased risk of colchicine toxicity

Interaction Deep Dive

CYP3A4 and P-gp both metabolize and transport colchicine, which is a substrate of each. Giving colchicine together with P-glycoprotein (P-gp) inhibitors such as dronedarone is contraindicated1. When colchicine has been combined with clarithromycin, an agent that inhibits both CYP3A4 and P-gp, fatal interactions and serious toxicities have been documented. Similar toxicities have also been seen with colchicine plus CYP3A4 inhibitors and with colchicine plus P-gp inhibitors. Furthermore, in patients who have renal or hepatic impairment, using colchicine alongside a dual CYP3A4 and P-gp inhibitor like dronedarone is contraindicated. When such combined use is necessary in individuals whose hepatic and renal function is normal, the colchicine dose must be modified, either by lowering the daily amount or by reducing how often it is given, and the patient must be monitored closely for colchicine toxicity3. Where the two are used together or where the inhibitor has been taken within the previous 14 days, the colchicine dose for treating a gout flare should be reduced to a single 0.6 mg dose, and any repeat dose should not be administered any sooner than 3 days. For prophylaxis against gout flares, cut the colchicine dose from an original 0.6 mg twice daily down to 0.3 mg once daily, or from an original 0.6 mg once daily down to 0.3 mg every other day. In patients with familial Mediterranean fever, the colchicine dose should not exceed a maximum of 0.6 mg per day (this may be administered as 0.3 mg twice daily). Watch for colchicine toxicity and stop colchicine right away if it is suspected2.

Why it happens (mechanism)

Inhibition of CYP3A-mediated metabolism of colchicine; inhibition of P-gp-mediated efflux transport of colchicine

How to manage this interaction

This combination is generally avoided. Your care team will decide the safest path, and there are clear steps they can follow.

  • Do not start, stop, or change either drug on your own. Keep taking what you were prescribed until you speak with your team.
  • If you have kidney or liver problems, this pairing is not used, so your team may choose a different option.
  • If both are needed and your kidneys and liver are normal, your colchicine dose may be lowered or spaced out further and you will be monitored more closely.
  • Watch for signs of colchicine toxicity (severe diarrhea, vomiting, muscle weakness or pain, numbness, unusual bruising or infection) and report them right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

2 reports — tap to read

a) In a pharmacokinetic study, taking a single 0.6 mg dose of colchicine together with ketoconazole 200 mg twice daily for 5 days (a potent CYP3A4 inhibitor) raised the colchicine Cmax by 101.7% and the AUC by 212.2% relative to baseline values (N=24) 2.

b) When a 0.6 mg dose of colchicine was administered alongside clarithromycin 250 mg twice daily for 7 days, colchicine Cmax and AUC rose by 227.2% and 281.5%, respectively, from baseline in a study involving 23 patients 2.

Common questions

Can I take Colchicine and Dronedarone together?

Dronedarone raises colchicine levels and this pairing is contraindicated, especially with kidney or liver impairment; do not combine without your care team specifically adjusting the colchicine dose and monitoring you closely. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Colchicine and Dronedarone interaction?

It is rated contraindicated. These should generally not be used together.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Colchicine and Dronedarone interaction managed?

This combination is generally avoided. Your care team will decide the safest path, and there are clear steps they can follow. Do not start, stop, or change either drug on your own. Keep taking what you were prescribed until you speak with your team. If you have kidney or liver problems, this pairing is not used, so your team may choose a different option. If both are needed and your kidneys and li… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Colchicine or Dronedarone need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: LODOCO(R) oral tablets, colchicine oral tablets. AGEPHA Pharma USA, LLC (per FDA), Parsippany, NJ, 2023. DailyMed
  2. Product Information: COLCRYS oral tablets, colchicine oral tablets. Takeda Pharmaceuticals America Inc (per FDA), Deerfield, IL, 2020. DailyMed
  3. Product Information: GLOPERBA(R) oral solution, colchicine oral solution. Romeg Therapeutics LLC (per FDA), Woburn, MA, 2019. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.